Programme

You can download the available power points by clicking on the name of the speakers in red.

 

WEDNESDAY, MARCH 9, 2016

07:30 – 09:00: Registration

09:00 – 12:00: IHN General Assembly

09:00 – 12:00: Education/training morning in French (open to all participants)
Certified “Développement Profesionnel des Connaissances“
Chairs: Rachid Djoudi and Nadia Oubouzar

(09:00 – 10:30)
– French national health authority recommendations for RBC and platelet transfusion: the “hot” topics. Mauricette Michallet and André Lienhart (France)

–  Plasma transfusion: best practice. Yves Ozier (France)

(10:30 – 11:00) Coffee Break

(11:00 – 11:30) Dry plasma: just for the battlefield? Anne Sailliol (France)
(11:30 – 12:00) Good bye TRALI, Good morning TACO. From pathophysiology to prevention. Philippe Renaudier (France) on behalf of the CNCRH

12:15 – 13:45: Lunch symposium organised by Macopharma
Chairs: Constantina Politis, Greece, and Jean-Pierre Allain, United Kingdom

– International, prospective, CRO-managed haemovigilance study on methylene blue-treated plasma. Ignacio Alvarez (Macopharma)
– Assessment of safety when methylene blue and quarantine plasma are used interchangeably. Walter Nussbaumer (Austria)

14:00 – 18:15: Opening Session: Twenty years of haemovigilance: what are the achievements, and where to from here?
Chairs: Erica Wood and Pierre Tiberghien

(14:00-14:55) Welcome and Opening. Erica Wood, President IHN and representatives of French health authorities and supporting organisations
(14-55-15:25) Haemovigilance in Europe: What do health authorities expect from haemovigilance? Deirdre Fehily (European Commission)
(15:25-16:20) Haemovigilance lessons and perspectives from around the world. Representatives from international haemovigilance systems, including Bernard Lassale (France), Brazil: Auristela Maciel Lins (Brazil), Steven Anderson (USA) and Dr Bisht (India)

(16:20-16:50) Coffee Break (Poster viewing and expo visits)

(16:50-17:20) How do we evaluate cost-effectiveness in transfusion and haemovigilance? Mart Janssen (The Netherlands)
(17:20-17:50) Haemovigilance: are we asking the right questions, and collecting and analysing the right information? Tjerk van der Schaaf( (The Netherlands)
(17:50-18:15) Panel discussion with audience participation

18:15 – 19:15: Welcome Reception on the exhibition floor

THURSDAY, MARCH 10, 2016

08:30 10:10: Plenary Session: Inflammation and its implications for blood donors and transfused patients
Chairs: Olivier Garraud and Martin Schipperus

 (08:30-09:00) Introduction to post-transfusion inflammation and the potential role of biological response modifiers. Olivier Garraud (France )
(09:00-09:30) 
What can “Omics” bring to transfusion medicine? Michel Prudent (Switzerland)
(09:30-10:00) TRALI : an update on risk factors, prevention and treatment. Alexander Vlaar (The Netherlands)

(10:00 – 10:30) Coffee Break (Poster viewing and expo visits)

10:30 – 11:45: Plenary Session: Sickle cell disease and hyperhaemolysis
Chairs: France Pirenne and Paula Bolton-Maggs

(10:30-11:00) Epidemiology, risk factors and new therapeutic approaches in France. France Pirenne (France)
(11:00-11:30) How do I treat DHTR?  Jo Howard (United Kingdom)
(11:30-11:45) Delayed hyperhemolysis transfusion reaction: An under-reported reaction in France. Claire Rieux (France)

11:45 – 13:15: Lunch symposium organized by Grifols: DO YOU HAVE THE FULL PICTURE OF YOUR TRANSFUSION PROCESS?

(11:50-12:00) Welcome and introduction
(12:00-12:30) Barcoding and computerization in improving the safety of transfusion. Jonathan Kay, United Kingdom
(12:30-13:00) 
Barcode technology for transfusion safety: the experience of Servizio di Immunoematologia e Medicina Trasfusionale di Biella. Gennaro. Mascaro, Italy
(13:00-13:10)
Q&A

13:15 – 13:45 Poster viewing (poster presenters to be in attendance at their posters) and expo visits

13:45 – 15:30: Plenary Session: Haemovigilance in Africa
Chairs: Jean-Pierre Allain and Jean-Claude Faber

(13:45-14:35) Donor and recipient vigilance in two key clinical trials in Africa
– Emergency evaluation of convalescent plasma for Ebola viral disease in Guinea. Nyankove Yves Haba (Guinea)
AIMS Trial (Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria). Alex Owusu-Ofori (Ghana)
 (14:35-15:30) Participating country presentations from Africa
   * Neo Moleli (South Africa)
   * Salam Sawadogo (Burkina Faso)
   * Michael Acquah (Ghana)
   * Abiyi Belay Ambaye (Ethiopia)

(15:30 – 16:00) Coffee Break (Poster viewing and expo visits)

16:00 – 18:30: Parallel Sessions
1) Tools for practice improvement
Chairs: Jean-Jacques Cabaud and Kevin Land
(16:00-16:40) Simulation as a tool for training. Antoine Tesniere and Alexandre Mignon (France)
(16:40-18:10) 6 Short presentations from selected abstracts:

– Horizon scanning through media mining to identify medical products of human origin-associated infectious risks: preliminary result of a pilot NOTIFY project study. Evangelina Petrisli (Italy/NOTIFY)
– Transfusion-related acute lung injury (TRALI) occurrence among female Medicaid beneficiaries of childbearing age, as recorded in large administrative databases in the US, during 2007-2010.  Mikhail Menis (USA)
– Incidence of plasma transfusion reactions and variance thereof – an analysis of 7 years of ISTARE data. (Nicholas Saadah, Netherlands/ISTARE)
– Duration of platelet storage and outcome of critically ill patients: results from analysis of Australian intensive care registry data. Cécile Aubron (France/Australia)
– Laboratory surveys from UK Transfusion Laboratory Collaborative (UKTLC) confirm cause for concern. Joanne Bark (United Kingdom)
– Donor safety in haemapheresis: implementation of the IHN Standard 2014 into the online system for assessment and evaluation of donor and apheresis complications. Hans-Gert Heuft (Germany)

(18:10-18:30) Panel discussion with audience  participation: Data and education to improve practice

2) Microbiological haemovigilance
Chairs: Syria Laperche and Lorna Williamson
(16:00-17:00)  Hepatitis E – to screen or not to screen? Lorna Williamson (United Kingdom) and Hans Zaaijer (The Netherlands)
(17:00-17:30) Look-back studies to assess microbiological risks. Syria Laperche (France)
(17:30-18:00) Changes in deferrals for MSM: implications for haemovigilance. Josiane Pillonel (France)
(18:00-18:30) Panel discussion with audience participation

 

Evening:  Participant Diner in the Musée du Vin

 

FRIDAY, MARCH 11, 2016

08:30 – 10:00: Parallel Sessions

1) Donor haemovigilance – Preventing and managing adverse reactions in donors
Chairs: Jo Wiersum and Xavier Tinard
(08:30-08:55) Detection and prevention of vasovagal reactions in blood donors. Mindy Goldman (Canada)
(08:55-09:10)- A prospective randomised study to reduce vasovagal reactions: the EVASION study results. Pierre Tiberghien (France)
(09:10-09:35) Young donors: assessing the risks. Peter Tomasulo (USA)

(09:35-10:05) 2 Short presentations from selected abstracts:

– Drinking water before whole blood donation does not reduce the incidence of vasovagal reactions in high-risk donors. Pairaya Rujirojindakul (Thailand)
– How to reduce delayed donor adverse reactions? Nuria Nomen Calvet (Spain)

2) Recipient haemovigilance
Chairs: Gerald Daurat and Hasan Abbas Zaheer
(08:30-09:00) Human factors and transfusion errors. Paula Bolton-Maggs (United Kingdom)
(09:00-09:30) Transfusion in crisis situations. Celine Roche and Patrick Jault (France)
(09:30-10:00) 2 Short presentations from selected abstracts

– Might TACO be the most critical safety concern? Education for junior doctors to improve TACO awareness and management. Gerald Daurat (France)
– Fatal adverse reactions associated with transfusion of blood components reported to ISTARE, 2006-2013. Constantina Politis (Greece/ISTARE)

(10:00 – 10:30) Coffee Break (Poster viewing and expo visits)

10:30 – 12:30: Plenary Session: Iron – not enough, or too much!
Chairs: Peter Tomasulo and Philippe Renaudier
(10:30-10:55) Current concepts in iron metabolism relevant to transfusion and haemovigilance. Pierre Brissot (France)

(10:55-11:20) Iron deficiency in donors: how to assess and prevent it? Kevin Land (USA)
(11:20-11:45) Hereditary haemochromatosis: implications for donors, products and patients. Gilles Follea (France)

(11:45-12:15) Transfusional iron overload. Joan Cid (Spain)
(12:15-12:35) A haemovigilance view of transfusion iron overload. Philippe Renaudier (France)

12:30 – 13:30: Awards and Closing Session
(12:35-12:45) Presentation of IHN Medal and Award. Erica Wood, IHN President, and awardees
(12:45-13:30) Invited Lecture (IHN Award winner lecture)

 

14:30 – 16:30: Open session for informal discussions on haemovigilance research ideas

Hosted by

cncrh

cncrh sfvtt
sfts ints
ctsa efs

Partners

cncrh sfvtt
sfts ints
ctsa

Agence Régionale de Santé (ACAL)
Diagast
Jub Solutions
MAK-SYSTEM